Strategies on how to Minimize the Rise of Enrollment Violations in Clinical Trials
Abstract:This article will discuss the increasing trend of protocol enrollment violations, how enrollment violations produces detrimental effects on premarket clinical trials, and how sponsors/CROs, sites and CRAs can help minimize future violations in an effort to increase subject safety and data integrity.
Trending Compliance Trainings
Use of Electronic Health Record Data (EHR) in FDA regulated clinical investigations
By - Rachelle D Souza
On Demand Access Anytime
By - Rachelle D Souza
On Demand Access Anytime
Trial Master File and Clinical Data Management Regulated by FDA
By - Carolyn Troiano
On Demand Access Anytime
By - Carolyn Troiano
On Demand Access Anytime
Annual Current Good Manufacturing Practices (cGMP) Training
By - Kelly Thomas
On Demand Access Anytime
By - Kelly Thomas
On Demand Access Anytime
Issues related to informed consent in clinical trials
By - Sarah Fowler Dixon
On Demand Access Anytime
By - Sarah Fowler Dixon
On Demand Access Anytime
You Recently Viewed
